Uganda Health Ministry Confirms Six New Cases of Ebola
Uganda's health ministry confirmed six additional Ebola cases on Tuesday, raising the national total to 15. The new infections were identified among contacts of earlier patients, with two recoveries, 12 currently hospitalized and one death reported. In response, Uganda has closed its border with the Democratic Republic of Congo, but the UN International Organization for Migration warns that closures are driving people to informal crossing points, heightening the risk of further spread. The World Health Organization notes the DRC outbreak has produced 321 confirmed and 116 suspected cases.
How AI Can Give Community Oncology Clinics a Clearer View of the Future
Oklahoma Cancer Specialists and Research Institute (OCSRI) partnered with AllyGPO to deploy the AI‑driven specialty drug platform AllyIQ. The system links clinical, operational and finance workflows, giving real‑time insight into purchasing, inventory and contract performance. Within nine months OCSRI cut...
Fulcrum Exploring a Potential Sale After FDA Sidelined Its Sickle Cell Drug
Fulcrum Therapeutics announced it will discontinue pociredir, its experimental sickle‑cell drug, after the FDA deemed safety concerns—particularly a class‑wide risk of secondary blood cancers—insurmountable. The setback triggered a strategic review that could lead to a sale, merger, or asset divestiture....
Hearing Loss Is Bad for the Whole Body – but New Treatments Are Coming
Hearing loss is increasingly recognized as a systemic health risk, linked to dementia, cardiovascular disease and higher mortality. Researchers at Columbia University and other institutions cite epidemiological data showing the condition’s rapid rise among aging populations. New drug pipelines aim...
FTC Requires Ascension Divestitures in $3.9B AmSurg Deal
The Federal Trade Commission issued a consent order requiring Ascension to divest seven AmSurg surgery centers to clear its $3.9 billion acquisition of the ambulatory provider. The divestitures target markets in Nashville, Panama City, Tulsa, Waco and Wichita, with six centers...
Novellia Raises $18M for Patient-Controlled Health Data Platform
Novellia announced an $18 million Series A round led by Spark Capital, bringing its total funding to $28 million. The AI‑enabled platform lets patients consolidate medical records from multiple providers and share de‑identified data with pharmaceutical researchers. CEO Shashi Shankar said the capital...
Buprenorphine Lowers Suicidality After Ketamine Treatment
A double‑blind, placebo‑controlled trial found that low‑dose buprenorphine administered after a single ketamine infusion reduced suicidal ideation by 76% in adults with major depressive or bipolar II disorder. Participants received sublingual buprenorphine (0.2‑0.8 mg) daily for four weeks, beginning 48 hours post‑ketamine. Both...
Eve Bender
UnitedHealthcare has been sued by the Massachusetts attorney general over an alleged $100 million Medicaid fraud scheme. The lawsuit alleges the insurer encouraged nurses to code members as sicker than they actually were, inflating reimbursement claims. The complaint characterizes the practice...
More Black Men to Benefit From Prostate Cancer Screening Trial
The UK government will invest £18 million (≈$22.5 million) to expand the Transform trial, inviting tens of thousands of Black men aged 45‑74 to receive prostate cancer screening. The trial adds genetic testing and rapid MRI to the standard PSA test to...
How to Encourage Deceased Organ Donation
Developing nations struggle with organ shortages, often attributing the gap to cost and complexity. Tunisia demonstrated that a modest, doctor‑led awareness program can significantly increase deceased donor registrations, bypassing the need for sweeping legal reforms. The sessions allow physicians to...
ASCO26: In Vivo Oncology Approaches Continue to Show Promise
At ASCO 2026, in‑vivo CAR‑T approaches demonstrated strong early efficacy across blood and solid cancers. Eli Lilly’s partner Kelonia reported a 100% overall response rate in 18 multiple myeloma patients treated with KLN‑1010, bolstering Lilly’s pending $7 bn acquisition. Strand Therapeutics showed...
Emerging Therapies for CNS Tumours: Key Clinical Trial Updates to Watch at ASCO 2026
At ASCO 2026, pivotal CNS‑tumor trials were presented, confirming that extending temozolomide cycles, adding neoadjuvant temozolomide, or implanting carmustine wafers (MAGMA, JCOG1703) does not improve overall or progression‑free survival in newly diagnosed glioblastoma. In contrast, innovative approaches showed promise: a...
Africa: An Ebola "Fortress Strategy" Will Fail - Lessons From the Past
A new Bundibugyo Ebola outbreak in eastern DRC and Uganda has surpassed 900 suspected and 130 confirmed cases, threatening mineral‑rich corridors. The U.S. response focuses on a "fortress" plan, including a 50‑bed quarantine field hospital in Kenya, while critics argue...
When Every Minute Counts: How the PM RAHAT Scheme Is Transforming Emergency Care in India
India’s PM RAHAT scheme, launched in February 2026, guarantees cashless emergency treatment for road‑accident victims up to ₹1.5 lakh (≈$1.8 k) for seven days. It leverages the “golden hour” principle, aiming to raise survival odds by roughly 50% through rapid, coordinated care. The program...
Inflammatory Risk Observed in Nearly 40% of Patients with HF
A global POSEIDON analysis of 11,809 heart‑failure patients found that roughly 39% exhibit high inflammatory risk, defined by hsCRP ≥ 2 mg/L. The prevalence is uniform across HFpEF, HFmrEF and HFrEF subtypes and is higher among women, obese individuals, and those with chronic...
What Data Delays Are Costing Healthcare — And Its Patients
Healthcare’s reliance on delayed data hampers clinical decisions, fraud detection, and benefit administration. Only 43% of U.S. hospitals routinely exchange interoperable data, leaving clinicians without timely external information. Real‑time insights could curb the $90 billion in improper payments across Medicaid, Medicare...
Biohybrid Microrobots Repair Spinal Cord by Combining Stem Cells with Magnetoelectric Nanoparticles
Researchers at ETH Zurich have created bio‑hybrid microrobots that pair neural progenitor stem cells with magnetoelectric nanoparticles, forming NPC‑bots that can be steered magnetically to spinal‑cord lesions. The nanoparticles translate external magnetic fields into localized electrical cues, accelerating stem‑cell differentiation...
Healthcare Identity Challenges Present Data Risks
Healthcare providers are grappling with patient‑identity verification because the United States lacks a national patient identifier. Without a universal ID, clinicians must piece together fragmented data sources to match patients to their clinical records, increasing the chance of errors. Patrick...
EAC Ministers Hold Urgent Talks on Ebola Outbreak
East African Community health ministers convened an extraordinary virtual meeting in Arusha to coordinate a regional response to the Bundibugyo Ebola outbreak that has spread from the Democratic Republic of Congo into Uganda. The bloc is activating nine mobile laboratories...
ASCO: Pfizer Scores in Lung, Colorectal and Prostate Cancer but Key Readouts Still to Come
Pfizer entered ASCO 2026 fresh from a $10.5 billion partnership with China’s Innovent Biologics, using the deal to reinforce its oncology pipeline. The company unveiled more than 40 abstracts, including late‑breakers that showed an 81% reduction in disease‑progression risk for Lobrena in...
Cardiac Arrest Detectable on Wrist-Worn Device
Researchers demonstrated that a wrist‑worn photoplethysmography device can automatically detect cardiac arrest events, including ventricular fibrillation and pulseless ventricular tachycardia, in a clinical setting. In the multicenter DETECT‑1b study of 49 patients undergoing subcutaneous ICD implantation or VT ablation, the...
AI for MSK Will Bend the Healthcare Cost Curve
AI‑powered agentic tools are being positioned to transform musculoskeletal (MSK) care, shifting treatment from costly surgery toward preventive and rehabilitative interventions. With up to 80% of Americans likely to experience lower‑back pain, hospitals face patient leakage that has already cut...
Meta Labs Pharmaceuticals, LLC - 725130 - 05/15/2026
The FDA issued a warning letter to Meta Labs Pharmaceuticals after a December 2025 inspection uncovered multiple violations. The agency determined that the company’s products—such as Diabetic Advantage, Yacon Root Extract, Nattokinase Max, Viral Immune Booster, Arthritis Bursitis Rheumatism, and Respiratory...
Aeroflex Industria De Aerosol Ltda. - 728186 - 05/22/2026
The U.S. Food and Drug Administration’s Center for Drug Evaluation and Research issued a Warning Letter to Aeroflex Industria de Aerosol Ltda., a Brazilian OTC drug manufacturer, after the company failed to respond to a 704(a)(4) records request sent on...
HealthPartners Neuroscience Center Research and Innovation - 725333 - 05/19/2026
The FDA issued a warning letter to HealthPartners Neuroscience Center Research and Innovation after a March 2025 inspection uncovered multiple Good Laboratory Practice (GLP) violations in non‑clinical studies of an investigational drug. Key deficiencies included failure to test mixture uniformity,...
As Amyloid Falls Out of Favor, Here’s Where Alzheimer’s R&D Is Headed Next
The Alzheimer’s drug development pipeline has expanded to 158 agents across 192 trials, with disease‑modifying strategies now representing 73% of the portfolio. Amyloid‑targeting candidates have dropped to 16% of the pipeline, while inflammation, immune modulation, neurotransmitter, and tau approaches are...
FDA Picks Nephrodite’s Implantable Dialysis System for TAP Pilot
Nephrodite’s Holly implantable continuous dialysis system has been selected for the FDA Total Product Life Cycle Advisory Program (TAP) pilot, joining a cohort of just 122 devices. The system previously earned Breakthrough Device Designation, positioning it for an accelerated regulatory...
Circio and GenAssist Collaborate on Gene Therapy for Muscle Disease and In Vivo Cell Therapy
Circio and GenAssist have launched a research partnership to create circVec‑enhanced AAV vectors for low‑dose, muscle‑targeted gene therapy and in‑vivo cell therapy. The collaboration blends Circio’s circular RNA expression technology with GenAssist’s tissue‑specific, liver‑de‑targeted capsids, aiming to cut systemic dosing...
Targeted Drug Shrinks Tumors In Hard-To-Treat Cancer
A new antibody‑drug conjugate (ADC) that delivers chemotherapy directly into cancer cells showed promising activity in a Phase II trial for women with recurrent or refractory uterine cancer. About one‑quarter of participants experienced tumor shrinkage, and more than half saw...
Drug and Device Manufacturer Communications With Payors, Formulary Committees, and Similar Entities – Questions and Answers
The FDA released a draft Level 1 revised guidance (docket FDA‑2016‑D‑1307) that answers common questions on how drug and device manufacturers may share health‑care economic information (HCEI) with payors, formulary committees and similar entities. Co‑authored by the Centers for Biologics, Devices...
M15 General Principles for Model-Informed Drug Development
The U.S. Food and Drug Administration has issued the final version of its M15 guidance, titled “General Principles for Model‑Informed Drug Development.” Developed under ICH, the document outlines best practices for planning, evaluating, and documenting MIDD evidence, and establishes a...
Controversy Surrounds CMS's Medicaid Work Mandate: Stakeholder Reactions and Policy Implications
On June 1, CMS issued an Interim Final Rule requiring certain adult Medicaid applicants and enrollees to complete an 80‑hour monthly work activity to retain eligibility. The rule outlines exemptions for pregnant individuals, people with disabilities, tribal members, caregivers, and those...
Senator Cassidy’s Final Health Test: Confirmation Hearings For CDC, FDA, Surgeon General
Senator Bill Cassidy, a physician‑turned‑lawmaker who lost the 2026 Louisiana primary, remains chairman of the Senate HELP Committee. In that role he will preside over confirmation hearings for the next heads of the CDC, FDA and the Surgeon General. The...
Electronic Health Records: Better Goals and Measures Would Improve Interagency Cybersecurity Collaboration
The GAO report finds the Federal Electronic Health Record Modernization office (FEHRM) has not established clear cybersecurity goals or performance metrics for the federal EHR, which DOD primarily secures. While FEHRM facilitates interagency coordination among DOD, VA, the Coast Guard...
Genentech Receives the US FDA Priority Review for Giredestrant as an Adjuvant Treatment of ER+ Early-Stage Breast Cancer
Genentech’s oral selective estrogen receptor degrader giredestrant has received FDA priority review for use as an adjuvant therapy in estrogen‑receptor‑positive, HER2‑negative, ESR1‑mutated early‑stage breast cancer. The filing is backed by the lidERA Phase III trial, which enrolled more than 4,100 patients...
Health Bill in House of Commons Draws Questions on Data Privacy, Inequalities, and Single Patient Record
The UK Health Bill’s second reading introduced a sweeping plan to modernise the NHS through AI, digitisation and a new Single Patient Record that links data without moving it. Ministers highlighted tighter data‑privacy safeguards, audit trails and "strongest available" cyber...
A Stitch-Free Future for Delicate Surgery: Shira Medtech Takes on Preventable Amputations
Shira Medtech, an Ahmedabad startup, is developing a low‑cost, implantable sutureless device for microvascular anastomosis, building on its patented Shira Clamp used since 2018. The new technology aims to eliminate hand‑suturing of vessels smaller than 2 mm, cutting operative time and...
NHS Seeks £45m Partner to Help Build Out Digital ‘Proxy’ Services
The NHS is launching a near‑$63.5 million procurement to build a national digital proxy service that lets parents, carers and other guardians manage appointments, prescriptions and health records on behalf of vulnerable patients through the NHS App, NHS.UK and NHS Login....
Innovators Join HTN Live 2026 Line Up
HTN announced Rackspace Technology as headline sponsor of HTN Live 2026, a collaborative event for NHS leaders on 16 September in Leeds. The agenda features innovators such as Nervecentre, Aire Logic, X‑on Health, Noveva, Civica, Restore Information Management and Imprivata,...
Quencher‐Enhanced Raman Scattering Probes With Large Scattering Cross‐Section for NIR‐II Surgical Navigation and Postsurgical Site Infection Management
Researchers introduced quencher‑enhanced Raman scattering (QERS), a plasmon‑free probe built from non‑fluorescent diammonium building blocks that dramatically boosts Raman signal while eliminating fluorescence background. The QERS probes operate in the second near‑infrared window (NIR‑II) with a Raman cross‑section of 1.27 × 10⁻¹⁹ cm²...
ASCO ‘26: Bispecifics Vs. ADCs, a ‘RAS’ Revolution and a Step Change in Prostate Cancer
At ASCO 2026, Merck’s ADC sac‑TMT and Akeso’s bispecific ivonescimab sparred in Phase 3 lung‑cancer trials, highlighting a safety‑efficacy trade‑off between antibody‑drug conjugates and bispecific antibodies. Revolution Medicines reported that its RAS‑targeting drug daraxonrasib almost doubled overall survival in pancreatic cancer,...
BMS Secures FDA Acceptance for Camzyos sNDA
FDA has accepted Bristol Myers Squibb’s supplemental NDA for Camzyos (mavacamten) to treat adolescents aged 12 to under 18 with symptomatic obstructive hypertrophic cardiomyopathy, granting priority review with a PDUFA target date of September 30, 2026. The decision follows the...
ASCO26: Symptom-Tracking App Helps Advanced Cancer Patients
Researchers at Hong Kong University tested the SUPPORT+ mobile app with more than 1,200 advanced‑cancer patients across six palliative‑care clinics. The app prompts weekly symptom questionnaires, offers self‑management advice, and escalates serious issues to nurses. Over an 18‑week trial, app...
Best Patient Journey Analytics Tools for Health Systems
Health systems struggle to see a complete patient acquisition journey because their analytics stack is fragmented across web, call tracking, scheduling and EHR platforms. The article reviews tools that address parts of this gap, from full‑journey solutions like LightTrail to...
Study: Red Sage More Effective than Saw Palmetto for Lower Urinary Tract Symptoms
A 12‑week, double‑blind pilot study compared a proprietary red sage extract (SAGX) with saw palmetto in 30 men aged 40‑80 who have mild‑to‑moderate lower urinary tract symptoms (LUTS). The SAGX group achieved a 4.6‑point drop in the International Prostate Symptom...
Hospitals See Diseases Resurge as Vaccinations Decline
Doctors across the United States are reporting a sharp uptick in vaccine‑preventable illnesses such as whooping cough, rotavirus, and other bacterial infections as childhood vaccination rates fall. The resurgence follows a nationwide measles spike, which experts view as a warning...
Focused on Work, Needed at Home: A Federal Caregiving Policy Might Help
The Family and Medical Leave Act (FMLA) offers up to 12 weeks of job‑protected, unpaid leave for eligible employees caring for a seriously ill parent, spouse or child. Roughly 60% of U.S. workers meet the eligibility thresholds, but two‑thirds avoid...
ASCO26: AZ Triplet Makes Waves in Frontline Liver Cancer
AstraZeneca’s three‑drug combo of Imfinzi, Imjudo and Lenvima, added to transarterial chemoembolisation (TACE), cut the risk of disease progression or death by 30 % in unresectable hepatocellular carcinoma. In the EMERALD‑3 trial the triplet extended median progression‑free survival (PFS) to 13 months...
La Cuna: Community-Led Spanish Perinatal Education and Social Needs Navigation for Hispanic Immigrant Families
La Cuna is a community‑led, Spanish‑language perinatal education and social needs navigation program launched in Arkansas for Hispanic immigrant families. From 2021‑2025 it served 498 participants, screening high rates of food insecurity (42‑45%), financial strain (43‑60%) and unemployment (38‑81%). The...
Updating California’s Adverse Childhood Experiences (ACEs) and Toxic Stress Risk Assessment and Response Algorithm
California’s ACEs Aware program, launched in 2020 to screen for adverse childhood experiences and toxic stress, has released an updated risk‑assessment and response algorithm. The revision was driven by a ten‑member national expert committee and validated through usability testing with...